Improving Transparency in Pharmaceutical Systems
Strengthening Critical Decision Points Against Corruption
Datos Bibliográficos
| ID | 19916626 |
|---|---|
| Autores | Jillian Clare Cohen, James A Cercone, James Cercone, Roman Macaya |
| Año | 2002 |
| Páginas | 1-108 |
| Fecha de publicación | 2002-10-01 |
| Open Access | No |
| Tipo | BOOK |
| Editorial | World Bank, Washington, DC (PUBLISHER) |
| DOI | 10.1596/20426 |
| OpenAlex | W1823749976 |
| Idioma | EN |
| Citas recibidas | 3 |
| Referencias citadas | 24 |
This study presents a diagnostic \n framework and methodology to evaluate a pharmaceutical \n system s vulnerability to corruption and to determine which \n corrupt practices can have a major impact on the system s \n ultimate efficiency. We thus provide: (a) a systematic and \n quantifiable assessment of the extent to which a country s \n pharmaceutical system is vulnerable to corrupt practices; \n and (b) the identification of potential actions to increase \n the system s resistance to corruption, and ultimately, \n improve access of the population to good quality, essential \n medicines. The diagnostic framework and methodology permit \n users to identify key decision points in the pharmaceutical \n supply and distribution system (registration, selection, \n procurement, distribution, service delivery and use); assess \n the extent to which a country s current policies and \n practices at each of these key decision points make the \n system vulnerable to corruption; and understand the range of \n options that could reduce this vulnerability. This \n diagnostic tool has been designed for use by World Bank \n health specialists involved in health lending operations \n that include pharmaceutical components, and their national \n counterparts to help them identify points of vulnerability \n in the pharmaceutical system, address these points, and thus \n help ensure that pharmaceutical expenditures are maximized. \n While developed in the context of the health systems of \n Latin America and the Caribbean (and implemented in a pilot \n study in Costa Rica), the methodology can be modified with \n ease so that it is applicable to other regions
Business · Computer security · Context (archaeology) · Geography · Language change · Procurement · Risk analysis (engineering) · Transparency (behavior) · Vulnerability (computing) · Computer Science · Corruption and Economic Development · Healthcare Systems and Reforms · Marketing · Pharmaceutical Economics and Policy
Seeds of Corruption
A Theory of Collective Reputations (with Applications to the Persistence of Corruption and to Firm Quality)
Why Don't Poor Countries Catch Up? A Cross‐national Test of an Institutional Explanation
Does "Grease Money" Speed Up the Wheels of Commerce?
Dodging the grabbing hand
Corruption
Institutions and Economic Performance
Political Order in Changing Societies
High-Level Rent-Seeking and Corruption in African Regimes
Measuring Governance, Corruption, and State Capture
Corruption and Growth
Law Enforcement, Malfeasance, and Compensation of Enforcers
A Theory of Misgovernance
Corruption and development
The market for public office
An Equilibrium Queuing Model of Bribery
Does Competition Kill Corruption
Corruption
Corruptible Law Enforcers
How Taxing is Corruption on International Investors
Supply and use of essential drugs in sub-Saharan Africa
Economic Development Through Bureaucratic Corruption
Can Social Sector Reform Make Adjustment Sustainable and Equitable? Lessons from Chile and Venezuela-p
| Obras citantes distintas | 3 |
|---|---|
| Citas por año | 0,18 |
| Intervalo de citas | 2009 - 2024 (16) |
| Velocidad de citación | recent |
| Altamente citado | No |